top of page

News and Articles

AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease"

Rarity PBC Secures Exclusive License from UCLA TDG to Advance a Life-Saving Gene Therapy for ADA-SCID

Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency

Donald Kohn awarded $14.7M CIRM grant to advance ADA-SCID gene therapy toward FDA approval

Donald Kohn awarded $14.7M CIRM grant to advance ADA-SCID gene therapy toward FDA approval

Gene therapy for ADA-SCID shows promise

Gene Therapy Brings Hope to Families Affected by Rare Immune Disorder

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency

5-year old with rare disorder awaits gene therapy treatment

Lunch and Learn: ADA-SCID Gene Therapy Update

bottom of page